Literature DB >> 474690

Results of keratoprosthesis.

G N Rao, H L Blatt, J V Aquavella.   

Abstract

The technique of keratoprosthesis was used in 21 cases of severe and intractable forms of keratopathy during the past 3 1/2 years. The results in terms of visual acuity were satisfactory in more than half the cases. Significant problems that occurred after this procedure included the diagnosis and management of glaucoma, vitreitis, and retroprosthetic membrane. There were no instances of extrusion of the keratoprosthesis nor were there any cases of endophthalmitis. However, one case developed necrosis of the tissue around the optical cylinder on the eyelid after surgery. Although its use is limited to only some forms of keratopathy, keratoprosthesis seems to offer a solution in cases where no other treatment is available.

Entities:  

Mesh:

Year:  1979        PMID: 474690     DOI: 10.1016/0002-9394(79)90465-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Strampelli's osteo-odonto-keratoprosthesis. Clinical and histological long-term features of three prostheses.

Authors:  R Ricci; I Pecorella; A Ciardi; C Della Rocca; U Di Tondo; V Marchi
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

2.  Preparation and in vivo investigation of artificial cornea made of nano-hydroxyapatite/poly (vinyl alcohol) hydrogel composite.

Authors:  Xu Fenglan; Li Yubao; Yao Xiaoming; Liao Hongbing; Zhang Li
Journal:  J Mater Sci Mater Med       Date:  2007-04       Impact factor: 3.896

3.  The soft keratoprosthesis.

Authors:  D R Caldwell
Journal:  Trans Am Ophthalmol Soc       Date:  1997

4.  Glass-metal keratoprosthesis: light and electron microscopical evaluation of experimental surgery on rabbit eyes.

Authors:  P L Cuperus; W L Jongebloed; P van Andel; J G Worst
Journal:  Doc Ophthalmol       Date:  1989-01       Impact factor: 2.379

5.  Vitreon, a short-term vitreoretinal tamponade.

Authors:  K J Blinder; G A Peyman; U R Desai; N C Nelson; W Alturki; C L Paris
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.